ARTICLE | Company News
OGS's Vevesca MAA accepted for review
July 12, 2001 7:00 AM UTC
Oxford GlycoSciences (LSE:OGS; OGSI) said the EMEA accepted for review the MAA for its Vevesca oral N-butyldeoxynojirimycin glucosyltransferase inhibitor ( OGT 918) to treat Gaucher disease. The submi...